Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: Role of ETa receptors

Hypertension

Volumn 39, Issue 2 II, 2002, Pages 679-684

  Ammarguellat, Fatima Z ^a   Gannon, Philippe O ^a   Amiri, Farhad ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Apoptosis; Endothelin; Fibronectin; Hypertension, mineralocorticoid; Myocardium

Indexed keywords

5 DIMETHYLAMINO N (3,4 DIMETHYL 5 ISOXAZOLYL) 1 NAPHTHALENESULFONAMIDE; CD31 ANTIGEN; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CONFERENCE PAPER; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HEART FAILURE; HEART MUSCLE FIBROSIS; HYPERTENSION; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; RAT; UNINEPHRECTOMY; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; DESOXYCORTICOSTERONE; FIBROSIS; HEART DISEASES; HYPERTENSION; MALE; MATRIX METALLOPROTEINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; VENTRICULAR REMODELING;

EID: 0036175568     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/hy0202.103481     Document Type: Conference Paper

References (41)

1. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats
2. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy
3. Myocardial fibrosis in DOCA-salt hypertensive rats: Effect of endothelin ET(A) receptor antagonism
4. A receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats
5. Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: Role of endothelin-1
6. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat
7. The role of matrix metalloproteinases in heart disease
8. Matrix metalloproteinasesand their inhibitors in connective tissue remodeling
9. Matrix metalloproteinases: Effectors of development and normal physiology
10. Inhibition of TNF-alpha, Induced Cytokine and Adhesion Molecule expression in glomerular cells in vitro and in vivo by transcription factor decoy for NF-kappab
11. Gene therapy of transplant arteriopathy by liposome-mediated transfection of endothelial nitric oxide synthase
12. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes
13. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats
14. Apoptosis in myocytes in end-stage heart failure
15. End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes
16. Bcl-2 intersects the NFkappaB signalling pathway and suppresses apoptosis in ventricular myocytes
17. xIAP induces cell-cycle arrest and activates nuclear factorkappaB: New survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells
18. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked IAP gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis
19. Apoptosis in aorta of DOCA-salt hypertensive rats: Effect of endothelin receptor antagonism
20. Production of hypertension with desoxycorticorticosterone acetate-impregnated silicone rubber implants
21. NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats
22. 1 vasopressin antagonism on small artery structure and vascular expression of preproendothelin-1 in DOCA-salt hypertensive rats
23. Blood pressure, resistance artery structure and mechanics in DOCA-salt-treated vasopressin-deficient Brattleboro rats Role of endothelin
24. ET(A)-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat
25. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
26. NF-kappa B: A lesson in family values
27. Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats
28. Oxidative stress and vascular damage in hypertension
29. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response
30. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway
31. An AP-1 binding sequence is essential for regulation of the human alpha2(1) collagen (COL1A2) promoter activity by transforming growth factor-beta
32. Smad-dependent transcriptional activation of human type VII collagen gene (COL7A1) promoter by transforming growth factor-beta
33. Atherosclerosis: An inflammatory disease
34. Role of nuclear factor-kappa B in atherogenesis
35. VCAM-1, but not ICAM-1 or MAdCAM-1, immunoblockade ameliorates DSS-induced colitis in mice
36. Rel/NF-kappa B transcription factors and the control of apoptosis
37. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B
38. Control of apoptosis by Rel/NF-kappaB transcription factors
39. X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-β signaling
40. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway
41. Mineralocorticoids, hypertension, and cardiac fibrosis